Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease
Ali R. Rezai, Pierre-François D’Haese, Victor Finomore, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 1, pp. 55-62
Closed Access | Times Cited: 101

Showing 1-25 of 101 citing articles:

Alzheimer's disease drug development pipeline: 2024
Jeffrey L. Cummings, Yadi Zhou, Garam Lee, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2024) Vol. 10, Iss. 2
Open Access | Times Cited: 105
The neuropathobiology of multiple sclerosis
Marcel S. Woo, Jan Broder Engler, Manuel A. Friese
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 7, pp. 493-513
Closed Access | Times Cited: 27
Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
Víctor A. Arrieta, Andrew Gould, Dong Hwan Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Focused ultrasound gene delivery for the treatment of neurological disorders
Rikke Hahn Kofoed, Isabelle Aubert
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 263-277
Open Access | Times Cited: 15
Alzheimer’s disease: insights into pathology, molecular mechanisms, and therapy
Qiuyang Zheng, Xin Wang
Protein & Cell (2024)
Open Access | Times Cited: 15
Emerging Wearable Acoustic Sensing Technologies
Tao Liu, Y. J. Mao, Hanjie Dou, et al.
Advanced Science (2025)
Open Access | Times Cited: 3
Crossing the blood–brain barrier: emerging therapeutic strategies for neurological disease
Josephine H Pedder, Adam M. Sonabend, Michael D Cearns, et al.
The Lancet Neurology (2025)
Closed Access | Times Cited: 3
Versatile Copper-Chalcogenide-Based Nanoparticles for the Treatment of Brain Diseases
Shuyang Xie, Hualong Liu, Ke Yang, et al.
Nano Biomedicine and Engineering (2025)
Open Access | Times Cited: 1
Exploiting the mechanical effects of ultrasound for noninvasive therapy
Meaghan A. O’Reilly
Science (2024) Vol. 385, Iss. 6714
Closed Access | Times Cited: 13
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney, et al.
CNS Drugs (2024) Vol. 38, Iss. 8, pp. 613-624
Open Access | Times Cited: 10
MR-guided focused ultrasound in movement disorders and beyond: Lessons learned and new frontiers
Elena Natera‐Villalba, María-Agustina Ruiz-Yanzi, Carmen Gasca‐Salas, et al.
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106040-106040
Closed Access | Times Cited: 9
Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping
Sua Bae, Keyu Liu, Antonios N. Pouliopoulos, et al.
Theranostics (2024) Vol. 14, Iss. 11, pp. 4519-4535
Open Access | Times Cited: 8
Sounding Out the Blood–Brain Barrier
Kullervo Hynynen
New England Journal of Medicine (2024) Vol. 390, Iss. 1, pp. 82-85
Closed Access | Times Cited: 7
Consensus Review on Strategies to Improve Delivery Across the BBB Including Focused Ultrasound
Keaton Piper, Jay I. Kumar, Joseph S. Domino, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 9, pp. 1545-1556
Open Access | Times Cited: 7
Blood Brain Barrier‐Crossing Delivery of Felodipine Nanodrug Ameliorates Anxiety‐Like Behavior and Cognitive Impairment in Alzheimer's Disease
Xiaofei He, Yuan Peng, Sicong Huang, et al.
Advanced Science (2024)
Open Access | Times Cited: 7
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 7
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system
Pancheng Zhu, Ignasi Simon, Ida Kokalari, et al.
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115275-115275
Closed Access | Times Cited: 6
[125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease
Christopher Liang, Cayz G. Paclibar, Noresa L. Gonzaga, et al.
Neurology International (2024) Vol. 16, Iss. 2, pp. 419-431
Open Access | Times Cited: 6
Scanning ultrasound-mediated memory and functional improvements do not require amyloid-β reduction
Gerhard Leinenga, Xuan Vinh To, Liviu‐Gabriel Bodea, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2408-2423
Open Access | Times Cited: 5
Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastoma
Nathan McDannold, Patrick Y. Wen, David A. Reardon, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 194-208
Closed Access | Times Cited: 5
Strategies for enhanced gene delivery to the central nervous system
Zhenghong Gao
Nanoscale Advances (2024) Vol. 6, Iss. 12, pp. 3009-3028
Open Access | Times Cited: 5
The road ahead to successful BBB opening and drug-delivery with focused ultrasound
Miguel López‐Aguirre, Marta Castillo-Ortiz, Ariel Viña-González, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 901-913
Closed Access | Times Cited: 5
The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications
William A. Banks, Elizabeth M. Rhea, May J. Reed, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 11, pp. 101760-101760
Open Access | Times Cited: 5
A review of temporal interference, nanoparticles, ultrasound, gene therapy, and designer receptors for Parkinson disease
Amanda D. Currie, Joshua K. Wong, Michael S. Okun
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Current clinical investigations of focused ultrasound blood-brain barrier disruption: A review
Phillip G. Durham, Alexandra Butnariu, Rizk Alghorazi, et al.
Neurotherapeutics (2024) Vol. 21, Iss. 3, pp. e00352-e00352
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top